US FDA Approves Lupin’s Valbenazine Capsules

As the pharmaceutical giant received approval for valbenazine capsules from the US Food and Drug Administration (FDA), its shares soared by more than 5% on Friday. Adults with tardive dyskinesia, a medical condition that affects movement and facial tics like lip-smacking and grimacing, are treated with this medication. According to Lupin, the US FDA FDA […]

Continue Reading

US FDA Approves Incyte’s Skin Cancer Therapy

Incyte Corp. reported that the monoclonal antibody Zynyz had received expedited approval from the U.S. health regulator for the treatment of an aggressive and rare adult skin cancer. The treatment was approved by the Food and Drug Administration of the United States for patients with Merkel cell carcinoma (MCC) whose cancer has recurred or spread […]

Continue Reading

US CDC Investigating Recalled Eye Drops

The majority of patients infected with Pseudomonas aeruginosa reported using artificial tears or eyedrops, according to the Centers for Disease Control and Prevention (CDC). This drug-resistant strain of bacteria caused severe injuries to 68 patients across the United States, including three deaths. According to the CDC, these cases involved ten distinct ophthalmic drug brands. Ezri […]

Continue Reading

US FDA Approved Caplin’s Thiamine Hydrochloride Injection

The pharmaceutical company Lupin made the announcement that its alliance partner Caplin Steriles’ multiple-dose vials of Thiamine Hydrochloride injection USP, 200 mg/2 mL (100 mg/mL) had been granted approval by the United States Food and Drug Administration (US FDA). According to IQVIA MAT for the twelve months ending December 2022, sales of Thiamine Hydrochloride Injection […]

Continue Reading